Running News and Research

RSS

Hospital treatment far from home: an interview with Paul Lindsell, Managing Director at MindMetre Research

This is a generally accepted piece of received wisdom amongst clinicians and care professionals, which MindMetre validated through a series of qualitative interviews that preceded our quantitative study.

21 Dec 2014

TSRI scientists discover new method for joining complex organic molecules

Chemists at The Scripps Research Institute have invented a powerful method for joining complex organic molecules that is extraordinarily robust and can be used to make pharmaceuticals, fabrics, dyes, plastics and other materials previously inaccessible to chemists.

18 Dec 2014

Wearable technology and data analytics in healthcare: an interview with Mark Taglietti and Bob Zemke

Wearables is very much an emerging trend and healthcare is leading this effort. Consumer technology, such as the FitBit, Jawbone, and others, are going to merge with medical devices that are already being used in hospitals today.

15 Dec 2014

Tips to allergy sufferers for easy breathing this holiday season

The many smells and tastes of the holidays that get so many in a festive mood can sicken others, thanks to allergic reactions. But with some seasonal savvy, allergy sufferers can breathe easy this festive time of year.

14 Dec 2014

Zylast selected as a winner of USAID Fighting Ebola Grand Challenge

Zylast products have been selected as one of only three initial winners of the USAID Fighting Ebola Grand Challenge. The announcement, made from the White House, introduces Zylast as a solution to "help healthcare workers on the front lines provide better care and stop the spread of Ebola."

14 Dec 2014

Reducing the risk of sudden cardiac arrest during sports

Time and again, the topic of sudden cardiac death grabs the public's attention when football stars or other top athletes collapse from cardiac arrest in front of the live cameras. This important issue has long been a concern of heart specialists, for cardiac arrest often hits young, apparently healthy and athletic people out of the blue.

11 Dec 2014

Saint-Gobain Seals provides OmniSeal® spring-energized seals to OEM’s in the medical miniature motor market

Saint-Gobain Seals continues to provide their dynamic OmniSeal® spring-energized seals to OEM’s in the medical miniature motor market, which allows them to provide a well-balanced sealed motor and an added sense of security to their surgical tool OEM’s. The medical market has been growing quite rapidly with the need for more portable applications that are unobtrusive and efficient but still powerful.

8 Dec 2014

Study reveals how elite Kenyan athletes succeed in long-distance races

The Journal of Applied Physiology has published an article by Jordan Santos-Concejero of the Faculty of Physical Activity and Sport Sciences of the University of the Basque Country, and entitled `Maintained cerebral oxygenation during maximal self-paced exercise in elite Kenyan runners'. This is a pioneering study in the world of the physiology of exercise, given that it describes for the first time that elite Kenyan athletes have greater brain oxygenation during periods of maximum physical effort, and which contributes to their success in long-distance races.

7 Dec 2014

Cellular Research announces commercial availability of Precise targeted RNASeq assays

Cellular Research today announced the commercial launch of its Precise targeted RNASeq assays. The company also announced the commercial availability of application-focused panels for the Precise assays, including panels designed for oncology, induced pluripotent stem cells and immunology.

5 Dec 2014

New Crime Victims' Institute series explores human sex trafficking

Human sex trafficking is a serious problem both domestically and internationally and enhanced education is necessary to address the risk factors for entry into the sex trade, the physical and mental health consequences of victimization, and institutional responses to victims, according to a new series published by the Crime Victims' Institute at Sam Houston State University.

5 Dec 2014

O2 Media acquires health and fitness e-retailer InboxFitness.com

O2 Media is pleased to announce that the company has acquired the health and fitness e-retailer InboxFitness.com.

3 Dec 2014

Mylan, CAS to raise funds and awareness for people living with HIV/AIDS

Mylan Inc. and the Canadian AIDS Society (CAS) today announced a joint initiative to raise funds and awareness for Canadians and people worldwide who are living with or at risk of HIV/AIDS.

2 Dec 2014

Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

Grand Challenges Canada, funded by the Government of Canada, today announced $1.2 million in funding for 11 new global health innovations implemented in member states of La Francophonie.

29 Nov 2014

Runners, walkers come together to participate in 3rd annual Thanksgiving Day 5K

Over 2,300 running enthusiasts and members of the community came together to participate in the third annual Thanksgiving Day 5K. Thousands of crew, volunteers and spectators supported the racers along the 3.1 mile route.

28 Nov 2014

FEI releases software development framework for interactive remote 2D and 3D visualization

FEI announced the release of RemoteViz for Open Inventor, a software development framework for interactive remote 2D and 3D visualization.

From Thermo Fisher Scientific – Electron Microscopy Solutions 27 Nov 2014

Dresden scientists get access to the World's second-fastest computer for cancer research

For their calculations, researchers at the Helmholtz-Zentrum Dresden-Rossendorf will now, starting in 2015, have access to the World's second-fastest computer. The Dresden research initiative is one of 56 projects the US Department of Energy has granted access to Titan as part of their INCITE program.

27 Nov 2014

Immune Pharmaceuticals closes underwriter's exercise of partial over-allotment option of 459,697 units

Immune Pharmaceuticals Inc., a clinical stage biopharmaceutical company that engages in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases and cancer, today completed the underwriter's exercise of partial over-allotment option of 459,697 units, at a price of $2.50 per unit, for gross proceeds of approximately $1.06 million, bringing the aggregate gross proceeds of the Company's previously announced underwritten public offering to $9.685 million.